ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,843 | -0.1% | 293,097 | +3.7% | 0.21% | -1.9% |
Q2 2023 | $35,873 | -3.7% | 282,555 | -2.0% | 0.21% | -10.1% |
Q1 2023 | $37,257 | +0.5% | 288,459 | +2.2% | 0.24% | -6.3% |
Q4 2022 | $37,073 | -99.9% | 282,378 | +2.3% | 0.25% | +3.3% |
Q3 2022 | $32,282,000 | +43.8% | 276,010 | +44.6% | 0.24% | +55.1% |
Q2 2022 | $22,452,000 | +805.3% | 190,865 | +902.8% | 0.16% | +953.3% |
Q1 2022 | $2,480,000 | -91.3% | 19,033 | -89.9% | 0.02% | -90.2% |
Q4 2021 | $28,655,000 | -7.3% | 187,756 | -1.8% | 0.15% | -20.3% |
Q3 2021 | $30,921,000 | +7.9% | 191,246 | +9.2% | 0.19% | +5.5% |
Q2 2021 | $28,654,000 | +10.1% | 175,093 | +1.3% | 0.18% | -6.7% |
Q1 2021 | $26,028,000 | -0.8% | 172,878 | -0.2% | 0.20% | -9.3% |
Q4 2020 | $26,235,000 | +12.4% | 173,180 | +0.5% | 0.22% | -5.7% |
Q3 2020 | $23,334,000 | -4.0% | 172,323 | -1.1% | 0.23% | -18.6% |
Q2 2020 | $24,316,000 | +28.0% | 174,262 | -1.2% | 0.28% | -36.2% |
Q1 2020 | $18,993,000 | – | 176,331 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |